{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:41:50Z","timestamp":1792694510190,"version":"4.5.0"},"reference-count":45,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T00:00:00Z","timestamp":1254787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:p>The present manuscript gives emphasis on recognizing different morphological variants of atypical fibroxanthoma (AFX), on validation of immunohistochemical markers and on discussing potential diagnostic pitfalls.<\/jats:p><jats:p> <jats:bold>Material and methods:<\/jats:bold> Histological features analyzed in 66 AFXs were: ulceration, morphological variants, growth pattern, location in the skin and vascular\/perineural invasion. The antibodies used were CK\u2010MNF116, CK\u2010AE1\/AE3, S100, smooth muscle actin, desmin, CD31 and EMA.<\/jats:p><jats:p> <jats:bold>Results:<\/jats:bold> The study included 59 males, 7 females, aged 55\u201395 years, mean 77 years. All developed on sun damaged skin. Ulceration was present in 50%. Morphological patterns were pleomorphic spindle and epithelioid cells (60.6%), predominantly spindle cells (19.7%), purely spindle\u2010cells (13.6%), and predominantly epithelioid cells (6.1%). Most were localized in the dermis (57.6%). An expansile (36.4%) rather than infiltrative (6.1%) growth into superficial subcutis was also noted. No vascular\/perineural invasion was seen. Additional changes were hemorrhagic and pseudoangiomatous areas (24.2%), granular cell change (22.7%), keloid\u2010like areas (9.1%), myxoid change (7.6%), osteoclast\u2010like giant cells (6.1%) and clear cell change (4.6%). AFXs were consistently negative for S100, CK\u2010MNF116, CK\u2010AE1\/AE3 and desmin. Focal positivity for SMA (45.2%), EMA (24.4%) and CD 31 (9.5%) was seen.<\/jats:p><jats:p> <jats:bold>Conclusions:<\/jats:bold> A diagnosis of AFX is still made by exclusion of other malignant neoplasms with similar morphology. Immunohistochemistry plays a crucial role in this distinction, but can also be misleading. This study expands the spectrum of non\u2010vascular CD31 positive tumors.<\/jats:p><jats:p>Luzar B, Calonje E. Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls.<\/jats:p>","DOI":"10.1111\/j.1600-0560.2009.01425.x","type":"journal-article","created":{"date-parts":[[2009,10,6]],"date-time":"2009-10-06T05:46:54Z","timestamp":1254808014000},"page":"301-309","source":"Crossref","is-referenced-by-count":133,"title":["Morphological and immunohistochemical characteristics of atypical fibroxanthoma with a special emphasis on potential diagnostic pitfalls: a review"],"prefix":"10.1111","volume":"37","author":[{"given":"Bo\u0161tjan","family":"Luzar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Calonje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,22]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"664","article-title":"Atypical fibroxanthoma. Proceedings of the 18th Annual Tumor Seminar San Antonio Society of Pathologists, 1961.","volume":"59","author":"Helwig EB.","year":"1963","journal-title":"Tex State J Med"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196411)17:11<1463::AID-CNCR2820171114>3.0.CO;2-E"},{"key":"e_1_2_8_4_2","first-page":"403","volume-title":"Enzinger and Weiss's soft tissue tumours","author":"Weiss SW","year":"2008"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb00114.x"},{"key":"e_1_2_8_6_2","first-page":"11","article-title":"Ultraviolet\u2010induced p53 mutations in atypical fibroxanthoma","volume":"145","author":"Dei Tos AP","year":"1994","journal-title":"Am J Pathol"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880354"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2006.00412.x"},{"key":"e_1_2_8_9_2","article-title":"Granular cell atypical fibroxanthoma: case report and review of the literature","author":"Wright NA","year":"2009","journal-title":"J Cutan Pathol"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.dad.0000246175.73447.3a"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2005.00326.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02904819"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2006.00427.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2002.290609.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1999.035005484.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1997.tb01573.x"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2003.01552_4.x"},{"key":"e_1_2_8_18_2","first-page":"105","article-title":"Atypical fibroxanthoma with osteoclast\u2010like multinucleated giant cells","volume":"14","author":"Ferrara N","year":"2000","journal-title":"In Vivo"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199704000-00012"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199702000-00012"},{"key":"e_1_2_8_21_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2340\/0001555574467470","article-title":"Atypical fibroxanthoma with osteoclast\u2010like giant cells","volume":"74","author":"Val\u2010Bernal JF","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1989.tb00017.x"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-200302000-00001"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1998.00567.x"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2009.01255.x"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2003.00077.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archderm.1980.01640250115030","article-title":"Atypical fibroxanthoma of the skin with osteoid production","volume":"116","author":"Chen KT.","year":"1980","journal-title":"Arch Dermatol"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2008.01084.x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.5858\/2007-131-1517-BPIDIP","article-title":"Best practices in diagnostic immunohistochemistry. Pleomorphic cutaneous spindle cell tumours.","volume":"131","author":"Folpe AL","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0560.2001.281005.x"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2006.00477.x"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.5858\/2001-125-0799-SCCDBH"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2006.00635.x"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31816b8fce"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2006.044206"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199612000-00008"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2004.00173.x"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0303-6987.2006.00406.x"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004280100521"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2007.00735.x"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200109000-00007"},{"key":"e_1_2_8_42_2","first-page":"82","article-title":"Endothelial cell markers CD31, CD34, and BNH9 antibody to H\u2010 and Y\u2010antigens\u2013evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor","volume":"7","author":"Miettinen M","year":"1994","journal-title":"Mod Pathol"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200604000-00014"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2005.00190.x"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0303-6987.2004.0145.x"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2006.00492.x"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0560.2009.01425.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0560.2009.01425.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T19:19:12Z","timestamp":1698693552000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0560.2009.01425.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,22]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1600-0560.2009.01425.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0560.2009.01425.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,22]]}}}